| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID12774 |
| PMID | 25910294 |
| Peptide Sequence | NA |
| Peptide Sequence in Publication | NA |
| Protein Name | NA |
| UniprotKB Entry Name | NA |
| Biofluid | Serum |
| M/Z | 5027.39 |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | NA |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | 6.36E-04 |
| Software | ClinProTools |
| Length of Peptide | NA |
| Cancer Type | Hepatocellular carcinoma |
| Database for Peptide search | NA |
| Modification | NA |
| Number of Patients | "serum from31 healthy volunteers and 32 HCC patients used for training models and validated on independent data of 31 HCC, 23 liver fibrosis and 33 healthy volunteers" |
| Regulation/Differential Expression | Downregulated in cancer vs Healthy |
| Validation | external cross validation done |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |